Novel Probes in an easy and fast procedure linked with imaging for the detection of pathogens
Hospital-acquired infections (HAIs) are a global burden affecting millions of patients each year, causing significant increases in patient morbidity and mortality. Crucial for better patient outcome but also to reduce healthcare costs is early pathogen identification for swift selection of appropriate antimicrobial therapy.
Direct Multiplex Imaging (DMI) is the combination of a novel DNA-based multiplex hybridization technology with automatic imaging. DMI enables fast, specific and reproducible identification of multiple pathogenic microorganisms directly from samples, providing evidence for timely decisions and a targeted antibiotic therapy.
DMI uses molecular DNA-beacons as probes that specifically bind to complementary ribosomal target sequences (rRNA) in microorganisms. Commonly used hybridization targets are 16S and 23S rRNA, as they contain highly species-specific regions. DNA-beacons are hairpin-shaped structures that consist of a probe sequence (loop) that binds to the respective target sequence and 3’ and 5’ ends (stem) carrying a fluorophore and a quencher. With probe hybridization, the stem opens and a fluorescent signal that can be detected by fluorescence microscopy is emitted.
DMI assays are performed in just a few easy steps. The patient sample is applied to the detection slide, treated with the multiplex probes and hybridized. The hairpin structure permits probe hybridization in just 10 minutes. The high sensitivity of the assay makes additional amplification steps superfluous. After hybridization, no washing steps are necessary, as the detection probes fluoresce only when bound to the perfectly matching target sequence.
Slides can be read manually or automatically scanned with the Metafer DMI Scanner, which captures and archives images automatically. Data review is straightforward with the clearly structured user interface and customizable reports. The total assay time including analysis, LIMS-compatible reporting and automated archiving takes just 35 minutes, with new results in continuous mode setting being available every five minutes.
Available are DMI assays for identification and differentiation of the major bacteremia causing pathogens and for identification of the principle bacteria associated with hospital acquired pneumonia.
Metafer is a highly flexible system and can be easily adapted to run other microbiological applications like digitization of Gram slides or automated tuberculosis sputum smear microscopy for detection and counting of mycobacteria.
MetaSystems’ imaging solutions beyond microbiology include Clinical Cytogenetics, Cancer Genetics and Cell Biology, Forensics, Pathology and Tissue Imaging, and Toxicology and Radiation Biology.
For a list of our reference customers, please click here.
This conference will enhance insights of digitalization, machine learning and personalized health in infectious diseases.
The world’s leading experts will come together to discuss the latest developments in infectious diseases, infection control and clinical microbiology. The congress committee is preparing a comprehensive scientific programme with keynote lectures, symposia, educational and oral sessions on parallel tracks. We look forward to seeing you along with thousands of your colleagues from around the globe in Paris.
Please select your country of residence. Choose International if your country is not listed.
Our internet site may contain information that is not approved in all countries or regions. To ensure accuracy of content, it is required that you select the site which is appropriate for your country of residence.
